# TREPROSTINIL
> **ANDA208906** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS · Approved 2023-04-03
## Drug
- **FDA Application Number:** ANDA208906
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TREPROSTINIL
- **Generic name:** Treprostinil
- **Active ingredients:** TREPROSTINIL
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** ACTAVIS LABS
- **First approval:** 2023-04-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208906)
---
*AI Analytics · CC0 1.0*